F10 and atrial fibrillation: Patients within 30 days of ischemic stroke were excluded from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation - Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial.